Precede Biosciences
Charlene O. is a skilled scientist with extensive experience in biosciences and molecular diagnostics. Currently serving as a Scientist in Development Operations at Precede Biosciences since February 2024, Charlene previously worked as a Genomics Scientist at C2i Genomics from August 2022 to February 2024. Charlene's career includes significant roles at Foundation Medicine as a Molecular Technologist III and II from November 2016 to July 2022, as well as a Laboratory Technologist position at Genuity Science from December 2019 to August 2020. Prior experience includes roles at VRL Eurofins Laboratories and Charles River Laboratories, where responsibilities encompassed molecular diagnostics and genetic engineering in FDA/CLIA environments. Charlene holds a Bachelor of Science degree in Biomedical/Molecular from Bridgewater State University.
This person is not in the org chart
This person is not in any offices
Precede Biosciences
1 followers
We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test uncovers actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. By partnering with developers of new medicines and advancing our own diagnostic tests, we’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.